arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

MEDICINOVA INC

MNOV
$1.34 0.00 (0.00%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
77 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Bearish
auto_awesome

Analytical Summary

MEDICINOVA INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $66.0M
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC -5.7%
FCF / Share $-0.07
Trailing P/E
Price / Book 1.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

77-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$186.98K
↑ +23.2%
Net Income Profit after all expenses
$-2.59M
↑ +9.7%
Operating Margin Operating profit as % of sales
-114.7%
↓ -2176.4%
FCF / Share Free cash flow per share
$-0.07
↑ +8.3%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
24
Cash Quality
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 26 years · 77 quarters